February 2, 2021
Onduo Health, the virtual diabetes coaching program backed by Verily (and to a lesser extent Sanofi), announced this morning that it is expanding its platform beyond Type 2 diabetes to include several other conditions frequent among its populations.
Multi-condition services focused on hypertension, pre-diabetes, weight loss and mental wellbeing – as well as underlying coaching support for dieting...
November 25, 2020
Taiwan-based diabetes management app Health2Sync and DAIKYO ASTAGE INCORPORATED, a Japan-based apartment management company, has partnered to provide health management services to residents in DAIKYO ASTAGE managed apartments in Japan.
The partnership also includes two local pharmacies, Primary Pharmacy Co., Ltd. and Yakuju Co., Ltd., and will commence in the city of Kawasaki City, Kanagawa...
August 17, 2020
The current moment of health innovation and investment spurred by the COVID-19 crisis seems to be accelerating, if not driving, the consolidation of the digital health space. While Teladoc and Livongo loom as the most striking recent example, Omada’s purchase of Physera in May was also bolstered by the pandemic and its follow-on effects, CEO Sean Duffy told MobiHealthNews in a recent interview....
July 29, 2020
A retrospective analysis of more than 2,000 Livongo Diabetes Prevention Program (DPP) participants found an average weight loss of 5.1% from baseline after 12 months, and 6.6% among those who designated as high engagers.
The study, conducted by Livongo and published in BMJ Open Diabetes Research & Care, honed in on the relationships between specific program behaviors and program engagement...
October 2, 2019
After their recent collaboration with Grab in August to ensure that medication is delivered within 90 minutes once the teleconsultation session is complete, Singapore-based digital health startup WhiteCoat announced earlier this week that they are partnering with Homage, an on-demand home caregiving services platform to launch a pilot telehealth programme that complements home-based care.
Glen Tullman (second from right) at work with the Livongo team. Photo courtesy Livongo.
September 11, 2019
Livongo isn’t the first company in the digital health space to IPO — at least, depending on how you define “digital health” it isn’t. But even if your definition is broad, Livongo stands out as one of the first companies to go public that’s really focusing on delivering healthcare, not just wellness, using consumer digital technologies.
“People expect us to represent this whole new industry that...
June 19, 2019
Digital chronic condition management company Vida Health has raised $30 million in a strategic Series C round.
Contributors to the round included Florida Blue parent company GuideWell Mutual Holding Corporation, telemedicine giant Teladoc Health and Workday Ventures, the investment arm of enterprise cloud software company Workday, all of which also announced new partnerships or integrations with...
March 20, 2019
Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management.
The Redwood City, California-based company started out in hypertension, but has been expanding into diabetes for the past year. OneTouch meters, formerly owned by Johnson & Johnson, are the first of a handful of glucometer brands the company intends...
January 30, 2019
Chronic condition management startup Livongo has acquired MyStrength, a Denver-based digital behavioral health company. The company did not disclose the acquisition price, but Livongo CEO Glen Tullman told MobiHealthNews the figure is in the tens of millions.
“This entry into behavioral was to complete what we call the whole person platform, and to be able to go to someone and say ‘Whatever...
January 2, 2019
Ochsner Health System in New Orleans has been using mobile technology to monitor and manage chronic disease patients since 2015. In that time, the doctors behind the program have learned a lot about how to implement such a system, as well as about how effective it can be.
“We’ve learned a lot,” said Dr. Richard Milani, Ochsner's chief clinical transformation officer and medical director of...